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Previewsof a hydrogen bond between the b-phos-
phate of incoming NTP and the motif D
lysine. The protonation state of this lysine
was also found to be critical for achieve-
ment of the close conformation. Further-
more, the ability of motif D to achieve
the catalytically competent conformation
seems to be hindered by binding of
an incorrect nucleotide, and this ability
continues to be affected after nucleotide
missincorporation. Indeed, the studies
by Yang et al. (2012) link the conformation
of motif D to the efficiency and fidelity of
nucleotide addition.
Single subunit nucleic acid polymer-
ases use the movement of an a helix
(helix O in A family and helix P in B family
polymerases) to control each step of
the nucleotide addition cycle (Figure 1).
Binding of incorrect nucleotides prevents
this a helix from adopting its closed state,
reducing incorporation efficiency (Steitz,1450 Structure 20, September 5, 2012 ª20122009). Helices O and P also possess an
analogous lysine to those of motif D of
RdRPs. Thus, motif D of RdRPs and the
O/P helices seem to be functionally
equivalent. Mutations on motif D also
have an important effect on polymeriza-
tion fidelity, similar to mutations in helices
O and P. In conclusion, motif D of RdRPs
and RTs appears as a new important
target for the control of viral fidelity in all
RNA viruses.REFERENCES
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The study of CRISPR/Cas systems for RNA-based prokaryotic immunity has emerged as a rapidly expanding
frontier in RNAbiology. In this issue ofStructure, Nam and colleagues provide new clues to deciphering these
complex systems in the characterization of a subtype I-C CRISPR/Cas complex.Studies of the recently discovered RNA-
guided adaptive immune defense sys-
tems of the prokaryotic world continue
to generate fascinating new discoveries
that lay out the diverse mechanisms of
this versatile response to invading genetic
material and changing environments (for
recent reviews, see Bhaya et al., 2011
and Wiedenheft et al., 2012). Genetic
loci consisting of repeat DNA sequences
called CRISPRs (clustered regularly
interspaced short palindromic repeats)
and associated operons encoding Cas
(CRISPR associated) proteins are present
in the genomes of roughly half of bacteriaand 90% of archaea or in some on
a plasmid (Bhaya et al., 2011). Since the
first suggestion that this was a nucleic
acid-based system akin to RNAi systems
in eukaryotes (Makarova et al., 2006),
studies have shown that this system is
capable of conferring resistance to virus
infection and disruption of plasmid trans-
fer (Barrangou et al., 2007; Marraffini
and Sontheimer, 2008). Although there
are obvious parallels between CRISPR/
Cas systems and RNAi in their use of
RNA-based targeting of exogenous nu-
cleic acid for degradation, the differences
between them are noteworthy. CRISPR/Cas systems are part of the bacterial
and archaeal genomes, and therefore,
the adaptation of these organisms to the
surrounding environmental challenges
can be passed on to daughter cells.
Furthermore, these loci can be quickly
altered by the addition of new sequences
to their ends (with deletion of older, less
useful, sequences), which allows for
speedy response to change. Also, these
systems display a broader target range,
as most have been shown to target
DNA, but at least one system was shown
to target RNA (Hale et al., 2009). Although
these systems have been characterized
Figure 1. Comparison of the E.coli Type I-C and B.halodurans Type I-E CRISPR/Cas Systems
(A) Organization of the Cas and CRISPR loci for the two subtypes. The Type I ‘‘signature’’ gene, Cas3, is shown in red. The remaining genes are colored based on
functional analogy and are subtype-specific, except for those in gray.
(B) Schematic of CASCADE organization for two subtypes, colored as in (A).
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Previewsas a mechanism for immunity against
foreign invaders, the ability to target
RNA suggests the possibility of their use
in gene regulation, although definitive
evidence for this is currently lacking.
CRISPR/Cas immunity is generated in
three steps. First, proteins from the Cas
locus process foreign genetic material to
produce short fragments (25–75 bp
long) called ‘‘spacers’’, which are added
to the end of the CRISPR locus. Next, the
CRISPR locus is transcribed to produce
pre-crRNA, which contains the spacer
sequences and intervening repeat se-
quences (encoding RNA stem loops),
which is subsequently processed by
endonucleases from the Cas locus into
the crRNAs. Finally, the crRNAs assemble
into a ribonucleoprotein complex with
more Cas proteins for the RNA-guided
recognition and degradation of foreign
genetic material (Wiedenheft et al.,
2012). Despite the common sequence of
events, CRISPR/Cas systems display
startling diversity and are organized into
three types (I–III) characterized by type-
specific ‘‘signature’’ proteins and several
subtypes (subtypes I-A through I-F, II-A
and IIB, III-A and III-B) with subtype-
specific proteins, distinct organization,
different repeat sequences in the CRISPR
RNA region, and differences in the
detailed molecular mechanisms (Makar-
ova et al., 2011). The molecular architec-
ture of the E.coli Type I-E CRISPR-
associated complex for antiviral defense
(CASCADE) complex was reported last
year, along with remarkable insight into
the assembly of the various Cas proteins
and the conformational changes accom-
panying target recognition (Wiedenheft
et al., 2011).In this issue of Structure, Nam et al.
(2012) present an extensive structural
and biochemical characterization of a
subtype I-C/Dvulg CRISPR/Cas system
of B. halodurans. Their report provides
new information that allows analysis of
both the differences and commonalities
in CRISPR/Cas subtypes I-E and I-C
(see Figure 1). This is an important addi-
tion to knowledge in the field, as it is
only the secondCRISPR/Cas interference
complex to be this extensively structurally
characterized. Using a combination of
X-ray crystallography, biochemistry, and
electron microscopy, the authors show
that the subtype-specific Cas5d protein
of the B.halodurans functions as pre-
crRNA endonuclease, which recognizes
the stem loop-containing repeat se-
quence with specificity for the 30 adjacent
region, cleaves at the 30 end of the hairpin
to produce crRNA, and assembles with
the crRNA into an interference complex
similar in architecture to E.coliCASCADE.
Although the E.coli system contains a
Cas5d homolog, Cas5e (or CasD), unlike
Cas5d., its role is not pre-crRNA cleavage
but rather interaction with the 50-end of
the crRNA (Figure 1) (Wiedenheft et al.,
2011). In an interesting twist, molecules
of Cas5d appear to bind to both the
stem-loop at the 30-end called the 30
handle and the 50-end of the crRNA
(50 handle), resulting in two copies per
CASCADE-like complex (Figure 1). Thus,
the identified Cas5d function is analogous
to that of both CasE and CasD of
E.coli CASCADE. According to the pre-
sented model, two other proteins of the
B.halodurans Cas operon, Csd1 and
Csd2, assemble into the complex, with
Csd1 at the 50 handle and Csd2 in multipleStructure 20, September 5, 2012 ªcopies along the spacer crRNA, similar in
position to E.coliCasA and CasC, respec-
tively (Wiedenheft et al., 2011). The work
also reports on the sequence specificity
of Cas5d and a putative endonucleolytic
catalytic triad, which is the first such char-
acterization of a Cas5 protein.
Significantly, the characterization of the
Type I-C/Dvulg CRISPR/Cas system indi-
cates that a common mechanism may
exist between the Type I systems but sug-
gests more surprises await in the func-
tional characterization of subtype-specific
Cas proteins. Despite the differences
between the B.halodurans and E.coli
systems described above, Nam et al.
(2012) show that the B.halodurans Cas
proteins, Cas5d, Csd1, and Csd2, are
capable of restoring silencing activity
when expressed in a Cas-deficient E.coli
strain in which all of the Cas proteins
have been deleted, leaving only the E.coli
Type I-E CRISPR locus intact. Therefore,
although there are slight differences in the
nature and organization of Cas subunits,
the pre-crRNA and crRNA recognition
sequences are similar enough between
the two organisms to allow for proper
crRNA biogenesis and the assembly of
a functional hybrid CASCADE complex.
Questions still remain regarding the
role of the other ‘‘mysterious’’ Cas
proteins within the Type I CRISPR/Cas
systems and how similar the molecular
mechanisms and ribonucleoprotein com-
plex architecture of other subtypes may
be. What is clear from the study of these
systems is that very little can be defined
purely from sequence comparisons and
that each one will have to be explored on
a structural and biochemical level to gain
full insight into their diverse mechanisms.2012 Elsevier Ltd All rights reserved 1451
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PreviewsHowever, research in this field is sure to
yield more fascinating insight into the
complexities of prokaryotic adaptation,
with the added benefit of generating
useful technology for applications such
as gene targeting and designer strains,
among many other exciting possibilities.
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